| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8511c9fc75173ef1eb760d571898f88a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4dd274c24003036409ab11605dcf9f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_85ad1317dff70746c52b9f8a7a26c2fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a00b3090200da4160be103777248c4a1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4178
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-551
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5513
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4178 |
| filingDate |
2003-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_07886143f320264b6c676b4b7cfd1586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df6c626978183a31347ca4002f18daf7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_043251231b12f60e691ac3b67ec27db2 |
| publicationDate |
2004-02-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2004011031-A1 |
| titleOfInvention |
Antipsychotic combination therapies and compositions of an alpha-2 adrenergic receptor antagonist and an atypical antipsychotic neuroleptic |
| abstract |
The present invention provides novel antipsychotic therapies and compositions useful therein and provides methods for identifying new candidate molecules for the treatment of psychosis based on the proportional binding affinities for α2 adrenergic and D2 dopamine receptors. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8575172-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8178316-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8759350-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006016192-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9387182-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609344-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9694009-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006083204-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013038200-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006016192-A2 |
| priorityDate |
2002-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |